Identifying Good Candidates for Active Surveillance of Ductal Carcinoma In Situ: Insights from a Large Neoadjuvant Endocrine Therapy Cohort

Ductal carcinoma in situ (DCIS) is a biologically heterogenous entity with uncertain risk for invasive ductal carcinoma (IDC) development. Standard treatment is surgical resection often followed by radiation. New approaches are needed to reduce overtreatment. This was an observational study that enr...

Descripción completa

Detalles Bibliográficos
Autores principales: Glencer, Alexa C., Miller, Phoebe N., Greenwood, Heather, Maldonado Rodas, Cristian K., Freimanis, Rita, Basu, Amrita, Mukhtar, Rita A., Brabham, Case, Kim, Paul, Hwang, E. Shelley, Rosenbluth, Jennifer M., Hirst, Gillian L., Campbell, Michael J., Borowsky, Alexander D., Esserman, Laura J.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: American Association for Cancer Research 2022
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10035518/
https://www.ncbi.nlm.nih.gov/pubmed/36970720
http://dx.doi.org/10.1158/2767-9764.CRC-22-0263

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10035518/
https://www.ncbi.nlm.nih.gov/pubmed/36970720
http://dx.doi.org/10.1158/2767-9764.CRC-22-0263

Ejemplares similares